Trademark: 97205537
Status Date
Monday, September 25, 2023
Filing Date
Thursday, January 6, 2022
Published for Opposition
Tuesday, June 28, 2022
Abandoned Date
Monday, September 25, 2023
5 Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Anti-cancer preparations; Protein arrays for diagnosing cancer; Biological preparations for the assessment of recurrence of cancer; Pharmaceutical products for the assessment of a treatment of viral and infectious diseases, for the assessment of treatment of cancer; assessment for anti-cancer preparations; assessment of protein arrays for diagnosing cancer
45 Providing a website via a global computer network featuring supportive personal stories on the subjects of health, cancer, cancer recovery and survival
44 Medical testing, prediction and assessment for diagnostic, prognosis and treatment purposes in the field of cancer research and disease classification; Providing medical, assessment and prediction information to medical professionals in the field of cancer and disease classification; Providing medical information, assessment and prediction to medical professionals on sensitivities of cancers to hormones and/or hormone therapies
10 Medical apparatus or device for assessing the recurrence of cancer; Medical diagnostic apparatus for assessing and predicting recurrence of cancer cells incorporating recorded operating system software; Medical nanites for assessing and predicting the recurrence of cancer; Medical nanorobots for assessing and predicting recurrence of cancer; Medical microrobots for assessing and predicting recurrence of cancer after treatment
42 Medical and scientific research in the field of assessing and predicting recurrence cancer after treatment and diagnosis; Medical research services in the field of assessing and predicting recurrence of cancer; Providing laboratory research services in the field of assessing and predicting effectiveness of treatment and diagnosis in gene expression, namely, cancer biology; Research and development of pharmaceuticals for the assessment and prediction of effectiveness of treatment of age-related diseases and cancer; Assessment and predictions of medical diagnosis and treatment of cancer; Providing information about medical research, predictions and assessments in the field of cancer
Sep 25, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 25, 2023
Abandonment - No Use Statement Filed
Feb 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 31, 2023
Sou Extension 1 Granted
Jan 31, 2023
Sou Extension 1 Filed
Jan 31, 2023
Sou Teas Extension Received
Jan 30, 2023
Teas Change Of Correspondence Received
Jan 30, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 30, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 23, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 28, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 28, 2022
Published For Opposition
Jun 8, 2022
Notification Of Notice Of Publication E-Mailed
May 25, 2022
Law Office Publication Review Completed
May 20, 2022
Assigned To Lie
May 18, 2022
Approved For Pub - Principal Register
May 3, 2022
Previous Allowance Count Withdrawn
May 3, 2022
Approved For Pub - Principal Register
May 3, 2022
Assigned To Examiner
Jan 10, 2022
New Application Office Supplied Data Entered
Jan 10, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
